Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.

Completed

Phase N/A Results N/A

Summary of Purpose

AiCure uses artificial intelligence and visual recognition technology to confirm medication ingestion. The software is available as an app and downloaded onto a smart phone. The single-site, parallel-arm, randomized controlled trial will test the feasibility and impact of using the platform in a stroke population. End points: usability, consistent use of the device, and optimization of treatment.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 July 2016.

1 Mar 2015 25 Mar 2015 1 Apr 2016 1 Apr 2016 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Parallel Assignment

Contacts